kpl-404
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 22, 2019 (NCT04497662)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314807 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06531395 | Phase 2 | Jul 17, 2024 | Kiniksa Pharmaceuticals, Ltd. |
| NCT05198310 | Phase 2 | Dec 14, 2021 | Kiniksa Pharmaceuticals, Ltd. |
| NCT04497662 | Phase 1 | Oct 22, 2019 | Kiniksa Pharmaceuticals, Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals, Ltd. | For profit | 3 | 3 | 2 | 2019 |
1 organizations
Page 1 / 1